Ark Invest CEO Cathie Wood Boosts Stake in Firms Making Breakthroughs in Gene Editing, AI Drug Development, and Obesity Drugs

Cathie Wood splurged millions in biotech this year on strong clinical progress, AI adoption, sales growth, wider outreach, and steady product pipelines.

Related Keywords

William Blair ,Cathie Wood ,Tony Coles ,Amgen ,Deutsche Bank ,Hc Wainwright Co ,Wells Fargo ,Morgan Stanley ,Barclays Capital ,Goldman Sachs ,Astrazeneca ,Ark Invest ,Wall Street ,Ark Genomic Revolution ,Prime Medicine ,Prime Editing ,Prime Editor ,Integrated Drug Creation ,Breakthrough Therapy Designations ,